← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2010Last known activity
Jan 23, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 4 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT02009306Overall official - principal investigatorPhase 4Jan 23, 2017
- NCT02009306Lead sponsorPhase 4Jan 23, 2017
- NCT02009306Reponsible party - principal investigatorPhase 4Jan 23, 2017
- NCT02407392CollaboratorN/AJul 1, 2015
- NCT02216383CollaboratorPhase 3Feb 1, 2015
- NCT01049672Lead sponsorN/ASep 1, 2010
- NCT01049672Reponsible party - principal investigatorN/ASep 1, 2010
- NCT01049672Overall official - principal investigatorN/ASep 1, 2010
Details
- Last known activity
- Jan 23, 2017